In the BioHarmony Drug Report Database

"Preview" Icon

Pramlintide

Symlin (pramlintide) is a protein pharmaceutical. Pramlintide was first approved as Symlin on 2005-03-16. It is used to treat type 1 diabetes mellitus and type 2 diabetes mellitus in the USA. It is known to target calcitonin receptor.

 

Trade Name

 

Symlin
 

Common Name

 

pramlintide
 

ChEMBL ID

 

CHEMBL2103758
 

Indication

 

type 1 diabetes mellitus, type 2 diabetes mellitus
 

Drug Class

 

Peptides: amylin derivatives or mimics

Image (chem structure or protein)

Pramlintide structure rendering